Ricardo González-Cámpora
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ricardo González-Cámpora has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
- García-Escudero
UGC Pathology, Hu Virgen Valme, Seville, Spain
7 shared publications - Ana Vallejo-Benítez
Servicio de Anatomía Patológica, Hospital Universitario Virgen Macarena, Sevilla, España
4 shared publications - Antonio Beato-Moreno
Departamento de Estadística e I.O., Universidad de Sevilla, 41012 Sevilla, Spain
3 shared publications - Antonio Lopez-Beltran
Department of Pathology, Cordoba University Medical School, Cordoba, Spain
3 shared publications - Hugo Galera-Ruiz
Department of Otolaryngology, Head and Neck Surgery, University of Seville, Seville, Spain
3 shared publications Angel Caunedo-Álvarez
2 shared publications
Latest Publications
- 1 October 2017
- Published by Elsevier in Annals of Diagnostic Pathology
- Vol. 30, 8-11
Expression of dog1 in low-grade fibromyxoid sarcoma: A study of 19 cases and review of the literature
- 1 October 2017
- Published by Elsevier in Annals of Diagnostic Pathology
- Vol. 30, 8-11
Expression of dog1 in low-grade fibromyxoid sarcoma: A study of 19 cases and review of the literature
- 15 February 2017
- Published by Elsevier in Revista Española de Patología
- Vol. 50 (2) , 89-99
Tumores del estroma gastrointestinal: breve actualización y consenso de la SEAP-SEOM sobre diagnóstico patológico y molecular
- 15 February 2017
- Published by Elsevier in Revista Española de Patología
- Vol. 50 (2) , 89-99
Tumores del estroma gastrointestinal: breve actualización y consenso de la SEAP-SEOM sobre diagnóstico patológico y molecular
- 1 October 2016
- Published by Elsevier in Revista Española de Patología
- Vol. 49 (4) , 234-238
Hiperplasia difusa idiopática de células neuroendocrinas de pulmón (DIPNECH): una entidad preneoplásica, infradiagnosticada y poco conocida
- 1 October 2016
- Published by Elsevier in Revista Española de Patología
- Vol. 49 (4) , 234-238
Hiperplasia difusa idiopática de células neuroendocrinas de pulmón (DIPNECH): una entidad preneoplásica, infradiagnosticada y poco conocida
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S851-S852
Tu1128 Stem Cells From Submucosal Glands as a Possible Origin for Barretts Esophagus Epithelium
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S851-S852
Tu1128 Stem Cells From Submucosal Glands as a Possible Origin for Barretts Esophagus Epithelium
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S1012
Tu2058 Usefulness of Immunohistochemical Biomarkers CD133, Racemase and Twist for Progression in Barretts Esophagus and Esophageal Adenocarcinoma
- 1 April 2016
- Published by Elsevier in Gastroenterology
- Vol. 150 (4) , S1012
Tu2058 Usefulness of Immunohistochemical Biomarkers CD133, Racemase and Twist for Progression in Barretts Esophagus and Esophageal Adenocarcinoma
- 1 November 2013
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 49 (11) , 494-496
Lipoma endobronquial: una causa poco frecuente de obstrucción bronquial
- 1 November 2013
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 49 (11) , 494-496
Lipoma endobronquial: una causa poco frecuente de obstrucción bronquial
- 1 April 2013
- Published by Elsevier in Revista Española de Patología
- Vol. 46 (2) , 93-100
Fibromixoma plexiforme del antro gástrico: descripción de 2 casos y revisión de la literatura
- 1 April 2013
- Published by Elsevier in Revista Española de Patología
- Vol. 46 (2) , 93-100
Fibromixoma plexiforme del antro gástrico: descripción de 2 casos y revisión de la literatura
- Open Access
- 1 March 2012
- Published by SciELO Espana/Repisalud in Revista Española de Enfermedades Digestivas
- Vol. 104 (3) , 128-133
Gastrointestinal stromal tumors (GISTs): role of CD 117 and PDGFRA Golgi-like staining pattern in the recognition of mutational status
Aims: determine whether potential correlations between CD117 to and PDGFRA might serve as an indication for targeted therapies. Material and methods: immunohistochemical expression of CD117 and PDGFRA was evaluated in 99 paraffin-embedded GISTs in conjunction with KIT and PDGFRA mutational status. Results: CD117-positive staining was noted in 93 out of 99 cases. The predominant staining pattern was cytoplasmic, either with or without membrane accentuation; in 44.5% of cases, a clear Golgi-like pattern was evident. Correlations were found be-tween KIT mutation and both CD117 expression (p = 0.006) and Golgi-like pattern (p = 0.026). Cytoplasmic PDGFRA-positive staining was detected in 87% of cases, both with and without membrane accentuation; in 8% cases an evident Golgi-like staining pattern was observed. A significant correlation was noted between PDGFRA mutations and Golgi-like staining pattern (p = 0.001). Moreover, 95% of PDGFRA-positive GISTs were also CD117-positive, suggesting that expression of the two markers is not mutually exclusive; most of these had mutations in KIT exon 11. PDGFRA-positive/CD117-negative tumors had mutations in PDGFRA, mainly in exon 18. PDGFRA-negative/CD117-negative staining was observed in 15% of cases, all of which displayed mutations in KIT exon 11. CD117-positive/PDGFRA-negative cases were characterized by mutations in KIT, mainly in exon 11. Conclusions: CD117 and PDGFRA staining are not exclusive, and the presence of a Golgi-like staining pattern for either, whilst not pathognomonic, is highly suggestive of KIT and PDGFRA mutated GISTs, respectively, and may be used with some reservations as an alternative indication for prescribing targeted therapies.
- 1 March 2012
- Published by SciELO Espana/Repisalud in Revista Española de Enfermedades Digestivas
- Vol. 104 (3) , 128-133
Open AccessGastrointestinal stromal tumors (GISTs): role of CD 117 and PDGFRA Golgi-like staining pattern in the recognition of mutational status
Aims: determine whether potential correlations between CD117 to and PDGFRA might serve as an indication for targeted therapies. Material and methods: immunohistochemical expression of CD117 and PDGFRA was evaluated in 99 paraffin-embedded GISTs in conjunction with KIT and PDGFRA mutational status. Results: CD117-positive staining was noted in 93 out of 99 cases. The predominant staining pattern was cytoplasmic, either with or without membrane accentuation; in 44.5% of cases, a clear Golgi-like pattern was evident. Correlations were found be-tween KIT mutation and both CD117 expression (p = 0.006) and Golgi-like pattern (p = 0.026). Cytoplasmic PDGFRA-positive staining was detected in 87% of cases, both with and without membrane accentuation; in 8% cases an evident Golgi-like staining pattern was observed. A significant correlation was noted between PDGFRA mutations and Golgi-like staining pattern (p = 0.001). Moreover, 95% of PDGFRA-positive GISTs were also CD117-positive, suggesting that expression of the two markers is not mutually exclusive; most of these had mutations in KIT exon 11. PDGFRA-positive/CD117-negative tumors had mutations in PDGFRA, mainly in exon 18. PDGFRA-negative/CD117-negative staining was observed in 15% of cases, all of which displayed mutations in KIT exon 11. CD117-positive/PDGFRA-negative cases were characterized by mutations in KIT, mainly in exon 11. Conclusions: CD117 and PDGFRA staining are not exclusive, and the presence of a Golgi-like staining pattern for either, whilst not pathognomonic, is highly suggestive of KIT and PDGFRA mutated GISTs, respectively, and may be used with some reservations as an alternative indication for prescribing targeted therapies.
- 24 December 2011
- Published by Elsevier in Pathology - Research and Practice
- Vol. 208 (2) , 74-81
Gastrointestinal stromal tumors (GISTs): CD117, DOG-1 and PKCθ expression. Is there any advantage in using several markers?
- 24 December 2011
- Published by Elsevier in Pathology - Research and Practice
- Vol. 208 (2) , 74-81
Gastrointestinal stromal tumors (GISTs): CD117, DOG-1 and PKCθ expression. Is there any advantage in using several markers?
- 1 December 2011
- Vol. 33 (6)
Molecular findings of nasopharyngeal carcinoma in a European population.
To explore biomolecular characteristics of a group of patients with nasopharyngeal carcinoma from European (Spanish) hospitals, addressing the pathogenesis of the tumor and the response to treatment.
- 1 December 2011
- Vol. 33 (6)
Molecular findings of nasopharyngeal carcinoma in a European population.
To explore biomolecular characteristics of a group of patients with nasopharyngeal carcinoma from European (Spanish) hospitals, addressing the pathogenesis of the tumor and the response to treatment.